Education
About Us
Working with TipRanks
Follow Us
Evoke Pharma (EVOK)
NASDAQ:EVOK
Total Valuation
Evoke Pharma has a market cap or net worth of $16.61M. The enterprise value is -$292.02K.
Market Cap$16.61M
Enterprise Value-$292.02K
Share Statistics
Evoke Pharma has 1,558,465 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,558,465
Owned by Insiders61.27%
Owned by Institutions26.23%
Financial Efficiency
Evoke Pharma’s return on equity (ROE) is -0.76 and return on invested capital (ROIC) is -42.66%.
Return on Equity (ROE)-0.76
Return on Assets (ROA)-0.31
Return on Invested Capital (ROIC)-42.66%
Return on Capital Employed (ROCE)-0.73
Revenue Per Employee3.42M
Profits Per Employee-1.78M
Employee Count3
Asset Turnover0.59
Inventory Turnover0.80
Valuation Ratios
The current PE Ratio of Evoke Pharma is ―. Evoke Pharma’s PEG ratio is 0.02.
PE Ratio―
PS Ratio0.82
PB Ratio1.20
Price to Fair Value1.20
Price to FCF-1.54
Price to Operating Cash Flow-7.61
PEG Ratio0.02
Income Statement
In the last 12 months, Evoke Pharma had revenue of 10.25M and earned -5.35M in profits. Earnings per share was -2.81.
Revenue10.25M
Gross Profit9.89M
Operating Income-5.20M
Pretax Income-5.35M
Net Income-5.35M
EBITDA353.31K
Earnings Per Share (EPS)-2.81
Cash Flow
In the last 12 months, operating cash flow was -3.32M and capital expenditures 2.00, giving a free cash flow of -3.32M billion.
Operating Cash Flow-3.32M
Free Cash Flow-3.32M
Free Cash Flow per Share-2.13
Dividends & Yields
Evoke Pharma pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.95
52-Week Price Change150.11%
50-Day Moving Average6.94
200-Day Moving Average4.65
Relative Strength Index (RSI)84.64
Average Volume (3m)29.82K
Important Dates
Evoke Pharma upcoming earnings date is Mar 12, 2026, TBA (Confirmed).
Last Earnings DateNov 13, 2025
Next Earnings DateMar 12, 2026
Ex-Dividend Date―
Financial Position
Evoke Pharma as a current ratio of 1.66, with Debt / Equity ratio of 117.24%
Current Ratio1.66
Quick Ratio1.62
Debt to Market Cap0.59
Net Debt to EBITDA1.74
Interest Coverage Ratio-10.38
Taxes
In the past 12 months, Evoke Pharma has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Evoke Pharma EV to EBITDA ratio is <0.01, with an EV/FCF ratio of <0.01.
EV to Sales>-0.01
EV to EBITDA<0.01
EV to Free Cash Flow<0.01
EV to Operating Cash Flow<0.01
Balance Sheet
Evoke Pharma has $11.58M in cash and marketable securities with $5.11M in debt, giving a net cash position of $6.46M billion.
Cash & Marketable Securities$11.58M
Total Debt$5.11M
Net Cash$6.46M
Net Cash Per Share$4.15
Tangible Book Value Per Share$3.69
Margins
Gross margin is 96.63%, with operating margin of -50.77%, and net profit margin of -52.22%.
Gross Margin96.63%
Operating Margin-50.77%
Pretax Margin-52.22%
Net Profit Margin-52.22%
EBITDA Margin-47.33%
EBIT Margin-47.33%
Analyst Forecast
The average price target for Evoke Pharma is ―, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target―
Price Target Upside―
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast67.40%
EPS Growth Forecast78.51%